5-96803547-C-G
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001040458.3(ERAP1):c.380G>C(p.Arg127Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.684 in 1,613,416 control chromosomes in the GnomAD database, including 381,926 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001040458.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERAP1 | NM_001040458.3 | c.380G>C | p.Arg127Pro | missense_variant | 2/19 | ENST00000443439.7 | NP_001035548.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERAP1 | ENST00000443439.7 | c.380G>C | p.Arg127Pro | missense_variant | 2/19 | 1 | NM_001040458.3 | ENSP00000406304.2 |
Frequencies
GnomAD3 genomes AF: 0.634 AC: 96341AN: 151902Hom.: 31278 Cov.: 31
GnomAD3 exomes AF: 0.637 AC: 160097AN: 251238Hom.: 52248 AF XY: 0.640 AC XY: 86937AN XY: 135790
GnomAD4 exome AF: 0.689 AC: 1006403AN: 1461396Hom.: 350635 Cov.: 74 AF XY: 0.686 AC XY: 498432AN XY: 726916
GnomAD4 genome AF: 0.634 AC: 96391AN: 152020Hom.: 31291 Cov.: 31 AF XY: 0.631 AC XY: 46906AN XY: 74330
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 84% of patients studied by a panel of primary immunodeficiencies. Number of patients: 74. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at